Sign in
EP1.01-61 iSEND Model as a Predictor of Efficacy in Immune Checkpoint Inhibitors for Non-Small Cell Lung Cancer: Fukushima Cohort
Journal article   Peer reviewed

EP1.01-61 iSEND Model as a Predictor of Efficacy in Immune Checkpoint Inhibitors for Non-Small Cell Lung Cancer: Fukushima Cohort

N Okabe, H Mine, H Takagi, M Watanabe, S Muto, T Hasegawa, Y Shio, W Park, G Lopes and H Suzuki
Journal of thoracic oncology, Vol.14(10), pp.S935-S935
2019-10

Metrics

7 Record Views

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

undefined

Source: InCites

Details